Characterizing barriers to care in patients with hidradenitis suppurativa
DOI:
https://doi.org/10.25251/zv612447Keywords:
barriers to care, diagnostic delay, healthcare costs, healthcare disparities, hidradenitis suppurativa, socioeconomic statusReferences
1. Nguyen TV, Damiani G, Orenstein LAV, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50-61. [PMID: 32460374].
2. Rick JW, Thompson AM, Fernandez JM, et al. Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey. Australas J Dermatol. 2021. [PMID: 34314017].
3. Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546-1549. [PMID: 26198191].
4. Marvel J, Vlahiotis A, Sainski-Nguyen A, et al. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ open. 2019;9(9):e030579. [PMID: 31575575].
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Josiah Williams, Veronica Emmerich, Emily Moya, Anita Rong, Steven Feldman, Rita Pichardo (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.